|
May 14
|
ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges
|
|
May 13
|
ClearPoint Neuro Reports First Quarter 2025 Results
|
|
May 12
|
ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing
|
|
Apr 28
|
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
|
|
Apr 27
|
The five-year returns have been incredible for ClearPoint Neuro (NASDAQ:CLPT) shareholders despite underlying losses increasing
|
|
Apr 25
|
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025
|
|
Apr 24
|
ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room
|
|
Feb 14
|
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025
|
|
Feb 12
|
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula
|
|
Jun 20
|
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
|
|
Jun 20
|
Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons
|
|
May 8
|
ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...
|
|
May 7
|
ClearPoint Neuro Reports First Quarter 2024 Results
|
|
May 2
|
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
|
|
Apr 29
|
ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
|
|
Apr 24
|
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
|
|
Apr 23
|
ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024
|
|
Apr 19
|
Is There Now An Opportunity In ClearPoint Neuro, Inc. (NASDAQ:CLPT)?
|
|
Apr 16
|
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
|
|
Mar 19
|
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
|